Core Insights - The 2025 World Artificial Intelligence Conference (WAIC) was held in Shanghai from July 26-28, attracting global attention in the AI field [1] - Chinese Premier Li Qiang attended the opening ceremony and delivered a significant speech, setting the development direction for the conference [3] - The conference featured 12 Nobel Prize and Turing Award winners, along with over 80 academicians, highlighting the importance of collaboration in the AI era [5] Company Highlights - Airdoc's AI innovations made it a focal point in the medical sector at WAIC, earning recognition as a representative of "local innovation globalization" [5] - The National AI Medical Health Application Base was unveiled, aiming to support the "AI + healthcare" national strategy through collaboration between Beijing Tongren Hospital, China Unicom, and Airdoc [6] - Airdoc's AI Chronic Disease Health Risk Assessment System is the first approved software for AI-assisted diagnosis of retinal diseases, capable of identifying 55 eye diseases and major chronic conditions [8] Industry Developments - The "Research Report on the Development Trends of AI Large Models in Healthcare" was released at WAIC, showcasing Airdoc's applications in various healthcare areas [8] - Airdoc's large model technology is expected to shift healthcare services from passive treatment to proactive prevention, creating a comprehensive smart healthcare ecosystem [10] - Airdoc received the "Local Innovation Globalization" award at WAIC for its contributions to equitable healthcare resource distribution and global green development [11] Product Innovations - Airdoc's CEO emphasized the importance of effective AI applications with clinical value, highlighting the company's impact on 30 million patients over the past decade [13] - The company showcased three AI product lines, including a microvascular examination device and an AI pressure detection instrument, which provide rapid and accurate health assessments [15][17] - Airdoc's AI-powered vision rehabilitation device has received regulatory approvals and accolades, offering sustainable solutions for managing myopia and other health issues [19] Future Outlook - Airdoc aims to continue its mission of making health accessible everywhere, focusing on innovation in the medical AI field to contribute to global healthcare development [20]

Core Insights - The 2025 World Artificial Intelligence Conference has highlighted the advancements and future developments in AI technology, particularly in the healthcare sector [1] - Eagle Vision Technology-B (02251), a leading AI medical company in the Hong Kong stock market, has gained attention with its three AI product lines, including an integrated AI diagnostic solution for retinal imaging [1] - The company's stock price rose by 7.03% to 14 HKD following the conference, reaching a peak of 14.36 HKD during trading [1] Company Developments - Eagle Vision Technology has implemented community outreach programs, providing AI-based eye screening and health risk assessments in various community service stations [1][2] - The AI retinal imaging system, Airdoc, can automatically capture retinal images in 1-3 minutes and accurately identify 55 types of eye diseases and associated health risks [3] - In 2024, the company served 7.1 million cases through its AI-assisted retinal detection products, identifying 35,600 significant positive cases, with a 39% increase in active service points to 7,883 [3] Market Trends - The integration of AI in healthcare is moving from conceptual phases to practical applications, driven by policy support and clinical needs [2] - The release of the "Expert Consensus on Eye Health Screening and Management for the Population (2024)" emphasizes the potential of AI in assisting diagnosis and addressing eye health management challenges [2] - The significant growth in the usage of AI for myopia prevention, with a 352.1% increase in usage and a 61.8% rise in user base, indicates a strong market demand for AI healthcare solutions [3]